Iterum Therapeutics (ITRM) Stock Chart & Stock Price History $1.26 -0.03 (-2.33%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.25 -0.01 (-0.40%) As of 03/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Iterum Therapeutics Stock Price Performance 5 Day Performance-10.64%1 Month Performance-9.68%3 Month Performance-30.00%6 Month Performance+15.60%Year-To-Date Performance-28.81%1 Year Performance-18.18% Receive ITRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address ITRM Stock Chart for Sunday, March, 30, 2025 ITRM Chart by TradingViewRemove Ads Iterum Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2025$1.29$1.26-2.33%$1.32$1.25196,209 shs$43.57 million03/27/2025$1.33$1.29-3.01%$1.34$1.29241,602 shs$44.61 million03/26/2025$1.41$1.33-5.67%$1.41$1.32348,751 shs$45.99 million03/25/2025$1.43$1.41-1.40%$1.48$1.39451,360 shs$48.76 million03/24/2025$1.44$1.43-0.69%$1.50$1.37257,876 shs$49.45 million03/21/2025$1.45$1.44-0.69%$1.49$1.42280,262 shs$49.80 million03/20/2025$1.45$1.45$1.47$1.42157,561 shs$50.14 million03/19/2025$1.38$1.45+5.45%$1.48$1.38461,657 shs$50.14 million03/18/2025$1.40$1.38-1.79%$1.43$1.37199,524 shs$47.55 million03/17/2025$1.38$1.40+1.45%$1.41$1.35184,670 shs$48.41 million Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/14/2025$1.34$1.38+2.99%$1.40$1.31198,530 shs$47.72 million03/13/2025$1.38$1.34-2.90%$1.39$1.34139,071 shs$46.34 million03/12/2025$1.34$1.38+2.99%$1.41$1.34171,552 shs$47.72 million03/11/2025$1.31$1.34+2.29%$1.36$1.27315,533 shs$46.34 million03/10/2025$1.38$1.31-5.07%$1.37$1.25552,366 shs$45.30 million03/07/2025$1.37$1.38+0.73%$1.39$1.35178,144 shs$47.72 million03/06/2025$1.36$1.37+0.74%$1.39$1.33133,465 shs$47.38 million03/05/2025$1.35$1.36+0.74%$1.40$1.33147,389 shs$47.03 million03/04/2025$1.33$1.35+1.50%$1.40$1.29373,569 shs$46.68 million03/03/2025$1.40$1.33-4.66%$1.46$1.32316,205 shs$45.99 million02/28/2025$1.37$1.40+2.05%$1.41$1.32219,939 shs$48.24 million Related Companies 4D Molecular Therapeutics Stock Price Chart Neumora Therapeutics Stock Price Chart CARGO Therapeutics Stock Price Chart Canopy Growth Stock Price Chart Contineum Therapeutics Stock Price Chart Kodiak Sciences Stock Price Chart Protalix BioTherapeutics Stock Price Chart Genfit Stock Price Chart ADC Therapeutics Stock Price Chart Acrivon Therapeutics Stock Price Chart Receive ITRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ITRM) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Iterum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
